Literature DB >> 22139835

Identification of interaction sites for dimerization and adapter recruitment in Toll/interleukin-1 receptor (TIR) domain of Toll-like receptor 4.

Celia Bovijn1, Peter Ulrichts, Anne-Sophie De Smet, Dominiek Catteeuw, Rudi Beyaert, Jan Tavernier, Frank Peelman.   

Abstract

Toll-like receptor signaling requires interactions of the Toll/IL-1 receptor (TIR) domains of the receptor and adapter proteins. Using the mammalian protein-protein interaction trap strategy, homology modeling, and site-directed mutagenesis, we identify the interaction surfaces in the TLR4 TIR domain for the TLR4-TLR4, TLR4-MyD88 adapter-like (MAL), and TLR4-TRIF-related adapter molecule (TRAM) interaction. Two binding sites are equally important for TLR4 dimerization and adapter recruitment. In a model based on the crystal structure of the dimeric TLR10 TIR domain, the first binding site mediates TLR4-TLR4 TIR-TIR interaction. Upon dimerization, two identical second binding sites of the TLR4 TIR domain are juxtaposed and form an extended binding platform for both MAL and TRAM. In our mammalian protein-protein interaction trap assay, MAL and TRAM compete for binding to this platform. Our data suggest that adapter binding can stabilize the TLR4 TIR dimerization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139835      PMCID: PMC3281722          DOI: 10.1074/jbc.M111.282350

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways.

Authors:  J L Slack; K Schooley; T P Bonnert; J L Mitcham; E E Qwarnstrom; J E Sims; S K Dower
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

2.  An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2.

Authors:  Xiao Tao; Yingwu Xu; Ye Zheng; Amer A Beg; Liang Tong
Journal:  Biochem Biophys Res Commun       Date:  2002-11-29       Impact factor: 3.575

3.  Design and application of a cytokine-receptor-based interaction trap.

Authors:  S Eyckerman; A Verhee; J V der Heyden; I Lemmens; X V Ostade; J Vandekerckhove; J Tavernier
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

4.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Authors:  K A Fitzgerald; E M Palsson-McDermott; A G Bowie; C A Jefferies; A S Mansell; G Brady; E Brint; A Dunne; P Gray; M T Harte; D McMurray; D E Smith; J E Sims; T A Bird; L A O'Neill
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

5.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.

Authors:  Y Xu; X Tao; B Shen; T Horng; R Medzhitov; J L Manley; L Tong
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

Review 6.  What the Myddosome structure tells us about the initiation of innate immunity.

Authors:  Nicholas J Gay; Monique Gangloff; Luke A J O'Neill
Journal:  Trends Immunol       Date:  2011-01-25       Impact factor: 16.687

7.  Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets.

Authors:  Tapani Ronni; Vishal Agarwal; Michael Haykinson; Margaret E Haberland; Genhong Cheng; Stephen T Smale
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses.

Authors:  Tamas Bartfai; M Margarita Behrens; Svetlana Gaidarova; Janell Pemberton; Alexander Shivanyuk; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

9.  Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection.

Authors:  Eugene Valkov; Anna Stamp; Frank Dimaio; David Baker; Brett Verstak; Pietro Roversi; Stuart Kellie; Matthew J Sweet; Ashley Mansell; Nicholas J Gay; Jennifer L Martin; Bostjan Kobe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

10.  LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Betsy J Barnes; Daniel R Caffrey; Alberto Visintin; Eicke Latz; Brian Monks; Paula M Pitha; Douglas T Golenbock
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

View more
  23 in total

Review 1.  Arterial Catheterization and Infection: Toll-like Receptors in Defense against Microorganisms and Therapeutic Implications.

Authors:  Zakary J Hambsch; Mitchell J Kerfeld; Daniel R Kirkpatrick; Dan M McEntire; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-08-14       Impact factor: 4.689

2.  Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions.

Authors:  Julianne Stack; Andrew G Bowie
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

3.  Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling.

Authors:  Thomas Ve; Parimala R Vajjhala; Andrew Hedger; Tristan Croll; Frank DiMaio; Shane Horsefield; Xiong Yu; Peter Lavrencic; Zahid Hassan; Garry P Morgan; Ashley Mansell; Mehdi Mobli; Ailis O'Carroll; Brieuc Chauvin; Yann Gambin; Emma Sierecki; Michael J Landsberg; Katryn J Stacey; Edward H Egelman; Bostjan Kobe
Journal:  Nat Struct Mol Biol       Date:  2017-07-31       Impact factor: 15.369

4.  Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling.

Authors:  Yoshiaki Enokizono; Hiroyuki Kumeta; Kenji Funami; Masataka Horiuchi; Joy Sarmiento; Kazuo Yamashita; Daron M Standley; Misako Matsumoto; Tsukasa Seya; Fuyuhiko Inagaki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-19       Impact factor: 11.205

5.  IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients.

Authors:  Sandra Weller; Mélanie Bonnet; Héloïse Delagreverie; Laura Israel; Maya Chrabieh; László Maródi; Carlos Rodriguez-Gallego; Ben-Zion Garty; Chaim Roifman; Andrew C Issekutz; Simona Eva Zitnik; Cyrille Hoarau; Yildiz Camcioglu; Júlia Vasconcelos; Carlos Rodrigo; Peter D Arkwright; Andrea Cerutti; Eric Meffre; Shen-Ying Zhang; Alexandre Alcais; Anne Puel; Jean-Laurent Casanova; Capucine Picard; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

6.  SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.

Authors:  Daniel W Summers; Daniel A Gibson; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

7.  TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin.

Authors:  Lee Swanson; Gajanan D Katkar; Julian Tam; Rama F Pranadinata; Yogitha Chareddy; Jane Coates; Mahitha Shree Anandachar; Vanessa Castillo; Joshua Olson; Victor Nizet; Irina Kufareva; Soumita Das; Pradipta Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-14       Impact factor: 11.205

8.  Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal).

Authors:  Celia Bovijn; Anne-Sophie Desmet; Isabel Uyttendaele; Tim Van Acker; Jan Tavernier; Frank Peelman
Journal:  J Biol Chem       Date:  2013-03-04       Impact factor: 5.157

9.  Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli.

Authors:  Greg A Snyder; Christine Cirl; Jiansheng Jiang; Kang Chen; Anna Waldhuber; Patrick Smith; Franziska Römmler; Nathaniel Snyder; Theresa Fresquez; Susanne Dürr; Nico Tjandra; Thomas Miethke; Tsan Sam Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

10.  An alanine-to-proline mutation in the BB-loop of TLR3 Toll/IL-1R domain switches signalling adaptor specificity from TRIF to MyD88.

Authors:  Brett Verstak; Christopher J Arnot; Nicholas J Gay
Journal:  J Immunol       Date:  2013-11-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.